Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials

Cited by (296)

Items 101–200 of 296

1. Telomere Length as a Marker of Biological Aging: A Critical Review of Recent Literature
   Stylianos Daios, A. Anogeianaki, Georgia D. Kaiafa, Anastasia Kontana, Stavroula Veneti, Christiana Gogou, Eleni Karlafti, Dimitrios Pilalas, Ilias Kanellos, Christos G. Savopoulos · 2022 · Current Medicinal Chemistry
2. Expert consensus on blood pressure management in critically ill patients
   Yuetian Yu, Ye Gong, Bo Hu, Bin Ouyang, Aijun Pan, Jinglun Liu, Fen Liu, Xiuling Shang, Xianghong Yang, Guo-Wei Tu et al. · 2023 · Journal of Intensive Medicine
3. Blood pressure-lowering drugs and secondary prevention of cardiovascular disease
   Wuxiang Xie, Fanfan Zheng, Εvangelos Εvangelou, Ou Liu, Zhenchun Yang, Queenie M Chan, Paul Elliott, Yangfeng Wu · 2018 · Journal of Hypertension
4. Has the SPRINT trial introduced a new blood-pressure goal in hypertension?
   Gema Ruiz‐Hurtado, José R. Banegas, Pantelis A. Sarafidis, Massimo Volpe, Bryan Williams, Luis Miguel Ruilope · 2017 · Nature Reviews Cardiology
5. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension. 11. Effects of total cardiovascular risk and achieved blood pressure
   Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti · 2017 · Journal of Hypertension
6. Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines? ― An Asian Perspective ―
   Sang‐Hyun Ihm, George L. Bakris, Ichiro Sakuma, Il Suk Sohn, Kwang Kon Koh · 2018 · Circulation Journal
7. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study
   Chao Li, Kangyu Chen, Victoria R. Cornelius, Ewan Tomeny, Yang Wang, Xiaowei Yang, Xiaodan Yuan, Rui Qin, Dahai Yu, Zhenqiang Wu et al. · 2021 · PLoS Medicine
8. Traditional risk factors for essential hypertension: analysis of their specific combinations in the EPIC-Potsdam cohort
   Violetta Andriolo, Stefan Dietrich, Sven Knüppel, Wolfgang Bernigau, Heiner Boeing · 2019 · Scientific Reports
9. Effect of mineralocorticoid antagonists on blood pressure lowering
   George Bazoukis, Costas Thomopoulos, Costas P. Tsioufis · 2018 · Journal of Hypertension
10. 5 Conservative treatment for PAD – Risk factor management
    Ulrich Frank, Sigrid Nikol, J. J. F. Belch · 2019 · VASA
11. Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)
    Irina Evgen'evna Chazova, Чихладзе Новелла Михайловна, Nataliya V. Blinova, Zhanna E. Belaya, Nikolai M. Danilov, Eugenia M. Elfimova, Aleksander Yu. Litvin, Liudmila Y. Rozhinskaya, Natalya Yu. Sviridenko, М.Ю. Швецов et al. · 2023 · Eurasian heart journal
12. A practical approach to the pharmacological management of hypertension in older people
    Nikesh Parekh, Amy Theresa Page, Khalid Ali, Kevin A. Davies, Chakravarthi Rajkumar · 2016 · Therapeutic Advances in Drug Safety
13. Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
    Stefano Omboni, Massimo Volpe · 2018 · Advances in Therapy
14. Impact of a Medication Therapy Management Clinic on Glycosylated Hemoglobin, Blood Pressure, and Resource Utilization
    Jessica J. Tilton, Mansi G. Edakkunnathu, Kellyn M. Moran, Anna Markel Vaysman, Jessica L. DaPisa, Brianna M. Goen, Daniel R. Touchette · 2018 · Annals of Pharmacotherapy
15. Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
    Stefano Omboni, Massimo Volpe · 2018 · Cardiovascular Therapeutics
16. Effects of vitamin D supplementation on 25(OH)D concentrations and blood pressure in the elderly: a systematic review and meta-analysis
    Farapti Farapti, Chusnul Fadilla, Niwanda Yogiswara, Merryana Adriani · 2020 · F1000Research
17. Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis
    Gianpaolo Reboldi, Fabio Angeli, Giorgio Gentile, Paolo Verdecchia · 2022 · European Journal of Internal Medicine
18. Hypertension Guidelines: Is It Time to Reappraise Blood Pressure Thresholds and Targets?
    Patricio A López-Jaramillo, António Coca, Ramiro Ariel Sanchez, Alberto Zanchetti · 2016 · Hypertension
19. Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry
    Emmanuelle Vidal‐Petiot, Emmanuel Sorbets, Deepak L. Bhatt, Grégory Ducrocq, Yedid Elbez, Roberto Ferrari, Ian Ford, Jean‐Claude Tardif, Michał Tendera, Kim Michael Fox et al. · 2018 · European Heart Journal
20. Acute and Chronic Hypertension
    Sherry L. Rivera, Jennifer Bourgeois Martin, Jessica B. Landry · 2019 · Critical Care Nursing Clinics of North America
21. Relationships Between Blood Pressure Reduction, Weight Loss, and Engagement in a Digital App–Based Hypertension Care Program: Observational Study
    OraLee H. Branch, Mohit Rikhy, Lisa A. Auster‐Gussman, Kimberly G. Lockwood, Sarah Anne Graham · 2022 · JMIR Formative Research
22. Antidiabetic drugs and blood pressure changes
    Ιoannis Ilias, Costas Thomopoulos, Helena Michalopoulou, George Bazoukis, Costas P. Tsioufis, Thomas Makris · 2020 · Pharmacological Research
23. European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice
    Lucas Lauder, Thomas Weber, Michael Böhm, Sofie Brouwers, Rosa María Bruno, Eva Gerdts, Reinhold Hugo Kreutz, Thomas Felix Lüscher, Giuseppe Mancia, John William McEvoy et al. · 2025 · Nature Reviews Cardiology
24. Treat to Target in Axial Spondyloarthritis: What Are the Issues?
    Abhijeet S. Danve, Atul A. Deodhar · 2017 · Current Rheumatology Reports
25. Methodological Aspects of Meta-Analyses Assessing the Effect of Blood Pressure–Lowering Treatment on Clinical Outcomes
    Mattias Brunström, Costas Thomopoulos, Bo Carlberg, Reinhold Kreutz, Giuseppe Mancia · 2021 · Hypertension
26. Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations
    Rahul Aggarwal, Jackson Steinkamp, Nicholas Chiu, Benjamin Petrie, Haares Mirzan · 2018 · Hypertension
27. Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024)
    Irina Evgen'evna Chazova, Чихладзе Новелла Михайловна, Nataliya V. Blinova, Аксенова Анна Владимировна, Tatiana A. Alekseeva, Lali G. Ambatiello, Yu. А. Balanova, Anna E. Bragina, Nikolai M. Danilov, O. M. Drapkina et al. · 2024 · Systemic Hypertension
28. Is It Time to Reappraise Blood Pressure Thresholds and Targets?
    Michael A. Weber, Neil R Poulter, Aletta Elisabeth Schutte, Louise M. Burrell, Masatsugu Horiuchi, Dorairaj Prabhakaran, Agustín José Ramirez, Ji‐Guang Wang, Ernesto L. Schiffrin, Rhian M. Touyz · 2016 · Hypertension
29. Management of Arterial Hypertension: 2018 ACC/AHA Versus ESC Guidelines and Perioperative Implications
    Alejandro Travieso-González, Ivan Javier Nuñez-Gil, Hynek Říha, José Antonio García Donaire, Harish Ramakrishna · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
30. Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
    Karpov IuA, Vladimir M. Gorbunov, N. A. Logunova · 2020 · Russian Journal of Cardiology
31. Defining the target: clinical aims in axial spondyloarthritis
    Helena Marzo‐Ortega, Katie Gaffney, Karl Gaffney · 2018 · Lara D. Veeken
32. Hypertension trials update
    Hussam Al Ghorani, Saarraaken Kulenthiran, Lucas Lauder, Michael Böhm, Felix Mahfoud · 2021 · Journal of Human Hypertension
33. High adherence to the Mediterranean diet and Alternative Healthy Eating Index are associated with reduced odds of metabolic syndrome and its components in participants of the ORISCAV-LUX2 study
    Kinda T. Alkoudsi, Farhad Vahid, Torsten Bohn · 2022 · Frontiers in Nutrition
34. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
    Irina Evgen'evna Chazova, Marina Vladimirovna Shestakova, Yu. V. Zhernakova, Nataliya V. Blinova, Т. Н. Маркова, Natalya Valentinovna Mazurina, Ежов Марат Владиславович, Sergey N. Tereshchenko, И. В. Жиров, Andrey L. Komarov et al. · 2021 · Eurasian heart journal
35. Optimal blood pressure target in stroke prevention
    Alexandra Yannoutsos, Céline Dreyfuss-Tubiana, Michel E. Safar, Jacques Blacher · 2016 · Current Opinion in Neurology
36. Hypertension guideline update
    Sondra M. DePalma, Cheryl Dennison Himmelfarb, Eric J. MacLaughlin, Sandra J. Taler · 2018 · JAAPA
37. Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials
    Mattias Brunström, Bo Carlberg · 2019 · BMJ Open
38. Impact of the SPRINT Trial on Hypertension Management
    Lama Ghazi, Suzanne Oparil · 2018 · Annual Review of Medicine
39. Monotherapy vs combination treatments of different complexity: a meta-analysis of blood pressure lowering randomized outcome trials
    Costas Thomopoulos, George Bazoukis, Guido M. Grassi, Costas P. Tsioufis, Giuseppe Mancia · 2021 · Journal of Hypertension
40. The lowest well tolerated blood pressure: A personalized target for all?
    P. Verdecchia, F. Angeli, G. Reboldi · 2024 · European journal of internal medicine
41. Blood pressure management in hypertensive patients with syncope: how to balance hypotensive and cardiovascular risk
    Giulia Rivasi, Michele Brignole, Martina Rafanelli, Grzegorz Bilo, Martino Francesco Pengo, Andrea Ungar, Gianfranco Parati · 2020 · Journal of Hypertension
42. Management of Postpartum Preeclampsia and Hypertensive Disorders (MOPP)
    Emily B. Rosenfeld, Deepika Sagaram, Rachel Lee, Ernani Sadural, Richard C. Miller, Ruby Lin, Deshae Jenkins, Kristin T. Blackledge, Ivana Nikodijevic, Alex Rizzo et al. · 2025 · JACC Advances
43. Target Blood Pressure for Treatment
    Enrico Agabiti Rosei · 2016 · Hypertension
44. Treatment Thresholds and Targets in Hypertension
    Costas P. Tsioufis, Costas Thomopoulos, Reinhold Hugo Kreutz · 2018 · Hypertension
45. Österreichischer Blutdruckkonsens 2019
    Österreichische Gesellschaft für Hypertensiologie, Thomas Weber, Österreichische Atherosklerosegesellschaft, Österreichische Diabetes Gesellschaft, Österreichische Gesellschaft für Internistische Angiologie, Österreichische Gesellschaft für Nephrologie, Österreichische Kardiologische Gesellschaft, Österreichische Gesellschaft für Neurologie, Österreichische Schlaganfall-Gesellschaft, Österr. Gesellschaft für Allgemeinmedizin et al. · 2019 · Wiener klinische Wochenschrift
46. Updated Reasons and Clinical Implications of New Korean Hypertension Guidelines for Cardiologists
    Jinho Shin, Myeong‐Chan Cho · 2020 · Korean Circulation Journal
47. A Multi-Parameter Fusion Method for Cuffless Continuous Blood Pressure Estimation Based on Electrocardiogram and Photoplethysmogram
    Gang Ma, Jie Zhang, Jing Liu, Lirong Wang, Yong Yu · 2023 · Micromachines
48. Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity
    Fosca Quarti‐Trevano, Gino Seravalle, Rita Facchetti, Konstantinos P Tsioufis, Kyriakos S. Dimitriadis, Eleni Manta, Giuseppe Mancia, Guido M. Grassi · 2025 · Hypertension
49. Treatment strategies for hypertension in patients with type 1 diabetes
    Alexandra Katsimardou, Konstantinos P. Imprialos, Konstantinos Stavropoulos, Alexandros G. Sachinidis, Michael N. Doumas, Vasilios Gabriel Athyros · 2020 · Expert Opinion on Pharmacotherapy
50. Tight versus standard blood pressure control on the incidence of myocardial infarction and stroke: an observational retrospective cohort study in the general ambulatory setting
    Bumsoo Park, Katarzyna Budzynska, Nada Almasri, Sumaiya Islam, Fanar Alyas, Rachel L. Carolan, Benjamin E. Abraham, Pamela A. Castro-Camero, Maria E. Shreve, Della A. Rees et al. · 2020 · BMC Family Practice
51. Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study
    the ATTICA Study group, Elena Critselis, Christina A. Chrysohoou, Natasa Kollia, Ekavi N. Georgousopoulou, Dimitrios M. Tousoulis, Christos S. Pitsavos, Demosthenes B. Panagiotakos · 2019 · Journal of Human Hypertension
52. Increased arterial stiffness and cardiovascular risk prediction in controlled hypertensive patients with coronary artery disease: post hoc analysis of FMD-J (Flow-mediated Dilation Japan) Study A
    Tatsuya Maruhashi, Junko Soga, Noritaka Fujimura, Naomi Idei, Shinsuke Mikami, Yumiko Iwamoto, Akimichi Iwamoto, Masato Kajikawa, Takeshi Matsumoto, Nozomu Oda et al. · 2020 · Hypertension Research
53. Therapeutic approaches to the Rational Use of triple combination therapy with a fixed combination of amlodipine, indapamide and perindopril arginine (TRIPLE COMBINATION) in patients with hypertension who do not control blood pressure on conventional treatment. (Description and main results of the TRIO program)
    Mareev VIu, Yu. V. Minina, Yu. L. Begrambekova, A. M. Levin · 2020 · Kardiologiia
54. Aiming higher in hopes to achieve lower: the European Society of Cardiology/European Society of Hypertension versus the American College of Cardiology/American Heart Association guidelines for diagnosis and management of hypertension
    Harsh Goel, Hesham Tayel, Sunil Kumar Nadar · 2019 · Journal of Human Hypertension
55. A Tale of 3 Trials: ACCORD, SPRINT, and SPS3. What Happened?
    Lawrence R. Krakoff · 2016 · American Journal of Hypertension
56. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)
    Brian P. Shapiro, Walter T. Ambrosius, Joseph L. Blackshear, William C. Cushman, Paul Kieran Whelton, Suzanne Oparil, Srinivasan Beddhu, Jamie P. Dwyer, Lisa H. Gren, William J. Kostis et al. · 2018 · Hypertension
57. Economic evaluation of a pharmacogenomic multi-gene panel test to optimize anti-hypertension therapy: simulation study
    Eli F. Kelley, Eric Michael Snyder, Nimer S. Alkhatib, Scott C. Snyder, Ryan S. Sprissler, Thomas Patrick Olson, Monica K. Akre, Ivo L Abraham · 2018 · Journal of Medical Economics
58. Should blood pressure goal be individualized in hypertensive patients?
    Alexandra Yannoutsos, Rania El Fekih, Jean‐Michel Halimi, Michel E. Safar, Jacques Blacher · 2016 · Pharmacological Research
59. The U-shaped association between achieved blood pressure and risk of cardiovascular events and mortality in elderly and younger patients
    Nam-Kyoo Lim, Hyun‐Young Park, Won–Ho Kim, Giuseppe Mancia, Myeong‐Chan Cho · 2020 · Journal of Hypertension
60. Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea
    Chang Hee Kwon, Woohyeun Kim, Jeong‐Hun Shin, Chan Joo Lee, Hyeon Chang Kim, Si‐Hyuck Kang, Mi‐Hyang Jung, Dae‐Hee Kim, Ju‐Hee Lee, Hack‐Lyoung Kim et al. · 2021 · Journal of the American Heart Association
61. New Challenges for Hypertension Treatment
    Martín Rosas-Peralta, Gladys Marcela Jiménez-Genchi · 2018 · Archives of Medical Research
62. Treatment of Hypertension with Nutrition and Nutraceutical Supplements: Part 1
    Mark C. Houston · 2018 · Alternative and Complementary Therapies
63. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis
    Lea Wagmann, Aline C. Vollmer, Lucas Lauder, Felix Mahfoud, Markus Robert Meyer · 2021 · Molecules
64. Kommentar zu den Leitlinien (2018) der Europäischen Gesellschaft für Kardiologie (ESC) und der Europäischen Gesellschaft für Hypertonie (ESH) für das Management der arteriellen Hypertonie
    Felix Mahfoud, Michael Böhm, Christa Bongarth, Ralph Bosch, Roland Erich Schmieder, Heribert Schunkert, Christoph Stellbrink, Peter Trenkwalder, Oliver Vonend, Joachim Weil et al. · 2019 · Der Internist
65. 2023 ESH Guidelines. What are the main recommendations?
    Paolo Verdecchia, Ehud Grossman, Paul Kieran Whelton · 2023 · European Journal of Internal Medicine
66. Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats
    Ying Xiao, Zhengyang Zhou, Jing-Chao Sun, Wei Xing, Jie Yan, Wenjie Xu, Yin‐Suo Lu, Tao Liu, Yi Jin · 2023 · Biomedicine & Pharmacotherapy
67. The Current Status of Devices for the Treatment of Resistant Hypertension
    Michael Kunz, Lucas Lauder, Sebastian Ewen, Michael Böhm, Felix Mahfoud · 2019 · American Journal of Hypertension
68. Multifaceted strategies to improve blood pressure control in a primary care clinic: A quality improvement project
    Cirous Sadeghi, Hassan A. Khan, Gregory D. Gudleski, Jessica L. Reynolds, Smita Bakhai · 2020 · International Journal of Cardiology Hypertension
69. Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MS
    Cathy M. Jacobs, Michael Kunz, Felix Mahfoud, Lea Wagmann, Markus Robert Meyer · 2021 · Analytica Chimica Acta
70. The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology
    Sandro Feriozzi, Yuri Battaglia, Calogero Lino Cirami, Concetta Gangemi, Gaetano La Manna, Loreto Gesualdo, María Lorenza Muiesan, Antonello Pani, Federico Pieruzzi, Flavio Luciano Ribichini et al. · 2025 · Journal of Nephrology
71. Blood pressure control measures and cardiovascular outcomes: a prospective hypertensive cohort
    Konstantinos Sideris, Ioannis Andrikou, Costas Thomopoulos, Fotis Tatakis, Maria G. Kariori, Eleni Manta, Theodoros Kalos, Στέργιος Σουλαϊδόπουλος, Sotirios Drogkaris, D. Konstantinidis et al. · 2022 · Blood Pressure
72. Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019
    J.A. Divisón, Julio Antonio Carbayo Herencia, Marta Simarro Rueda, Francisca Molina Escribano, Carlos Escobar, L.M. Artigao-Rodenas, Vicente Francisco Gil-Guillén, José R. Banegas · 2023 · Hypertension
73. Asking the Patient or Measuring Blood Pressure in the Emergency Department: Which One is Best?
    Per H. Skoglund, Per Svensson · 2016 · Current Hypertension Reports
74. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco, Grant, Peter J, Aboyans, Victor, Bailey, Clifford J, Ceriello, Antonio, Delgado, Victoria, Federici, Massimo, Filippatos, Gerasimos, Grobbee, Diederick E, Hansen, Tina Birgitte et al. · 2020 · European Heart Journal
75. Drugs for hypercholesterolaemia – from statins to pro-protein convertase subtilisin kexin 9 (PCSK9) inhibition
    Anthony S. Wierzbicki, Paul S Grant · 2016 · Clinical Medicine
76. Impact of Sex on Office White Coat Effect Tail: Investigating Two Italian Residential Cohorts
    Xavier Humbert, Sophie Fédrizzi, Joachim Alexandre, Alessandro Menotti, Alain Manrique, Martino W. Laurenzi, Emmanuel Touzé, Paolo Emilio Puddu · 2019 · Scientific Reports
77. Clinical characteristics and quality assessment of the treatment of patients with chronic heart failure with diabetes mellitus
    N. V. Lazareva, Е. В. Ощепкова, А. A. Orlovsky, S. N. Тereschenko · 2020 · Terapevticheskii arkhiv
78. Prevención de ictus en pacientes con hipertensión arterial: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
    Manuel Rodríguez‐Yáñez, Manuel Jesús Gómez-Choco, Elena López-Cancio M., Sergio Amaro, María Alonso de Leciñana, Juan Francisco Arenillas, Óscar Ayo Martín, Mar Castellanos, María del Mar Freijo, Á. García Pastor et al. · 2020 · Neurología
79. Does mean systolic blood pressure less than 130 mm Hg ensure high rates of control to <140/<90 mm Hg? A cross-sectional analysis of two cohorts
    Brent M. Egan, Susan E. Sutherland, Benjamin P. Martin, Benjamin Riesser, Andrew Edward Moran, Anthony Rodgers, Michael Rakotz · 2025 · BMJ Open
80. Difference in 24‐hour urine sodium excretion between controlled and uncontrolled patients on antihypertensive drug treatment
    Moo‐Yong Rhee, Sang‐Ho Jo, Jihyun Kim, Kwang‐Il Kim, Deuk-Young Nah, Sun‐Woong Kim, Namyi Gu, Ki‐Chul Sung, Kyung-Soon Hong, E.-J. Cho et al. · 2019 · Journal of Clinical Hypertension
81. Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed
    George S. Stergiou, Michael N. Doumas, Αναστάσιος Κόλλιας, Vasilios Papademetriou · 2016 · Journal of the American Society of Hypertension
82. FEATURES OF ARTERIAL HYPERTENSION IN PATIENTS WITH COMORBIDITY
    Anna I. Chesnikova, В. А. Сафроненко, N. S. Skarzhinskaya, А. В. Сафроненко, O. E. Kolomatskaya · 2017 · Medical Herald of the South of Russia
83. Liraglutide reduces systolic blood pressure in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials
    Di Zhao, Hui Liu, Pingshuan Dong · 2019 · Clinical and Experimental Hypertension
84. Hypertension defined by the 2017 ACC/AHA guideline is more accurate than 2018 ESC/ESH for detecting early vascular aging in young adults
    Mariana P. de Souza, Paulo Cesar Lopes, Gabriel Bazo, Paulo Ricardo H. Rocha, Daniela Aparecida Lorencini, Heloisa Bettiol, Marco Antonio Barbieri, Eduardo B. Coelho · 2022 · Medicine
85. Causal associations between blood pressure and the risk of myocardial infarction: A bidirectional Mendelian randomization study
    Zhiqiang Yang, Tingting Fan, Zheng Wang, Wan-Ting Zhou, Zhen-Xian Wang, Yan Tan, Qi Wu, Banglong Xu · 2022 · Frontiers in Cardiovascular Medicine
86. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
    Irina Evgen'evna Chazova, Yu. V. Zhernakova, Nataliya V. Blinova, Т. Н. Маркова, Natalya Valentinovna Mazurina, И. В. Жиров, Tatiana M. Uskach, Alfiya A. Safiullina, Olga Iu. Mironova, Eugenia M. Elfimova et al. · 2022 · Eurasian heart journal
87. Treatment optimisation for blood pressure with single-pill combinations in India (TOPSPIN) – Protocol design and baseline characteristics
    Gaia Kiru, Ambuj Roy, Dimple Kondal, Ambalam M. Chandrasekaran, Somnath Mukherjee, Bishav Mohan, Kavita Singh, Hyndavi Salwa, Edmin Christa, Ameeka Shereen Lobo et al. · 2024 · International Journal of Cardiology Cardiovascular Risk and Prevention
88. Target Blood Pressure Values in Ambulatory Blood Pressure Monitoring
    Katarzyna Lewandowska, Stanisław Wasiliew, Agata Kukfisz, Michał Hofman, Patrycja Woźniak, Artur Radziemski, Łukasz Stryczyński, Dawid Lipski, Andrzej Tykarski, Paweł Uruski · 2022 · High Blood Pressure & Cardiovascular Prevention
89. BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?
    Hemal Bhatt, Lama Ghazi, David A. Calhoun, Suzanne Oparil · 2016 · Current Cardiology Reports
90. Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies
    Yun Zhang, Mingming Liang, Chenyu Sun, Guangbo Qu, Tingting Shi, Min Min, Yile Wu, Yehuan Sun · 2019 · Journal of Human Hypertension
91. Lower or higher blood-pressure targets for high-risk patients?
    Alberto Zanchetti · 2016 · Nature Reviews Cardiology
92. New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences
    Zhanna D. Kobalava, Елена Алексеевна Троицкая, E. L. Kolesnik · 2019 · Rational Pharmacotherapy in Cardiology
93. Hypertension and Its Ocular Manifestations
    Ivy Zhu, William F. Mieler, Stella K. Kim, Frederick A. Jakobiec · 2022 · Springer eBooks
94. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension
    Flávio Danni Fuchs, Sandra Cristina Pereira Costa Fuchs, Carlos Eduardo Poli‐de‐Figueiredo, José Albuquerque de Figueiredo Neto, Luíz Cesar Nazário Scala, José Fernando Vilela-Martin, Leila Beltrami Moreira, Hilton Chaves, Marco Mota Gomes, Marcos Roberto de Sousa et al. · 2017 · Journal of Hypertension
95. The value of assessing cerebrovascular reactivity in hypertension and comorbid pathology
    Tatiana M. Ripp, N. V. Rebrova · 2021 · Arterial’naya Gipertenziya (Arterial Hypertension)
96. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials
    Chao Li, Kangyu Chen, Guoshuai Shi, Rui Shi, Zhenqiang Wu, Xiaodan Yuan, Vicky Watson, Zhixin Jiang, Hui Mai, Tian Yang et al. · 2022 · BMC Medicine
97. Optimal Target Blood Pressure and Risk of Cardiovascular Disease in Low-Risk Younger Hypertensive Patients
    Chang Hee Kwon, Jeonggyu Kang, Ara Cho, Yoosoo Chang, Seungho Ryu, Ki‐Chul Sung · 2019 · American Journal of Hypertension
98. Hypertension Across the Atlantic: A Sprint or a Marathon?
    Massimo Volpe, Barbara Citoni, Roberta Coluccia, Allegra Battistoni, Giuliano Tocci · 2017 · High Blood Pressure & Cardiovascular Prevention
99. Hypertension in the Elderly
    José Alfie, Paula Edit Cuffaro · 2019 · Elsevier eBooks
100. Risks of High Blood Pressure and Goals for Treatment
     Flávio Danni Fuchs · 2017 · Springer eBooks